Complement System Activation and Degradation

The complement system is a cascade of plasma and membrane proteins that, once triggered, amplifies through sequential proteolytic activation to opsonize pathogens, recruit inflammatory cells, and form membrane attack complexes. Several complement proteins are acute-phase reactants, and the activation fragments they release link complement directly to inflammation and to laboratory assessment of immune activity.

Definition

Complement activation is the sequential, self-amplifying proteolytic cascade of complement proteins — initiated by the classical, lectin, or alternative pathway — that converges on C3 cleavage to drive opsonization, inflammatory cell recruitment, and membrane attack, under tight regulation that also degrades and inactivates its components.

Scope

This entry describes the three activation pathways, the central amplification step, the effector outcomes, the regulatory and degradation controls, and the way complement components and activation products are measured in the laboratory. It is a reference description of the system and its analytes, not a source of diagnostic cut-offs or treatment guidance.

Core questions

• What are the three pathways that initiate complement activation?
• Why is C3 cleavage the central convergence point?
• How do anaphylatoxins link complement to inflammation?
• How is the cascade regulated and its components degraded?

Key concepts

• Classical, lectin, and alternative pathways
• C3 convertase and central amplification
• Anaphylatoxins (C3a, C5a)
• Opsonization (C3b)
• Membrane attack complex (C5b-9)
• Regulatory proteins and inactivation
• Complement proteins as acute-phase reactants

Mechanisms

Complement is triggered by three routes: the classical pathway (typically antibody- or CRP-bound surfaces), the lectin pathway (mannose-binding lectin recognizing microbial carbohydrates), and the alternative pathway (continuous low-level activation amplified on permissive surfaces). All converge on cleavage of C3 by a C3 convertase, generating C3b for opsonization and C3a as an anaphylatoxin; downstream cleavage of C5 yields C5a, a potent inflammatory mediator, and C5b initiates assembly of the membrane attack complex (C5b-9). A network of fluid-phase and membrane regulators limits and inactivates these steps to protect host cells, and the cascade generates short-lived split products that can be measured to gauge activation. Several complement proteins rise during the acute phase response.

Clinical relevance

Complement activation links the acute phase response to innate immune effector functions, and complement components and their activation fragments are measured in the laboratory to assess immune activity and complement consumption. This entry describes the system and its analytes at a reference level and does not provide diagnostic thresholds or treatment guidance.

Epidemiology

Complement participates in host defence and in a range of inflammatory, infectious, autoimmune, and degenerative conditions, and complement-directed therapies have expanded interest in measuring pathway activity. Its breadth makes complement assessment relevant across many areas of medicine.

Evidence & guidelines

The pathways, effector functions, and regulation of complement are set out in authoritative reviews (Walport, 2001, Parts 1 and 2; Ricklin et al., 2010), and its place among acute-phase reactants is noted in the acute phase response literature (Gabay & Kushner, 1999). This entry summarizes that material at a reference level rather than as guideline direction.

History

Complement was identified at the turn of the twentieth century as a heat-labile serum activity that complemented antibody in lysing bacteria, work associated with Jules Bordet and Paul Ehrlich. Through the twentieth century the protein components, the classical and alternative pathways, and later the lectin pathway were defined, and the regulatory network and activation fragments were characterized, yielding the integrated cascade described today.

Debates

How is complement activation best measured and interpreted?

Total pathway assays, individual component levels, and split-product measurements each capture different aspects of activation and consumption, and which best reflects in vivo activity in a given setting remains a methodological discussion.

Key figures

• Mark Walport
• John Lambris
• Daniel Ricklin
• Jules Bordet

Seminal works

• walport-2001-part1
• walport-2001-part2
• ricklin-2010

Frequently asked questions

Why is C3 considered the centre of the complement cascade?

All three activation pathways converge on cleaving C3, which produces C3b for opsonization and feeds the downstream steps; because of this convergence, C3 activation is the central amplifying event of the system.

How does complement connect to the acute phase response?

Several complement proteins are positive acute-phase reactants that rise during inflammation, and CRP can activate the classical pathway, so complement is both regulated by and a participant in the systemic inflammatory response.